Abstract
Intuitive Machines will report second-quarter 2026 results on August 13, 2026 Pre-MKt; investors will focus on revenue conversion from its backlog, gross margin resilience under contract-mix shifts, and any updates to full-year guidance.Market Forecast
Consensus centered on the company’s own forecasts points to revenue of 216.33 million US dollars for the current quarter, up 224.78% year over year, with an estimated EPS of -0.10 and an EBIT of -15.08 million US dollars; margin guidance for gross and net profitability was not provided. The quarter’s operational highlights are expected to revolve around milestone deliveries under fixed‑price missions and reimbursable engineering services, with attention to cost control amid rapid scale-up. The segment with the strongest runway is fixed‑price mission execution, anchored by 162.09 million US dollars of revenue last quarter within a total revenue base that expanded 198.65% year over year, positioning it as the core driver as contracted milestones unlock.Last Quarter Review
Intuitive Machines posted revenue of 186.73 million US dollars with a 16.12% gross margin; GAAP net loss attributable to shareholders was 37.39 million US dollars for a -20.02% net margin, and adjusted EPS was -0.25, down 127.27% year over year. A notable highlight was the scale-up in operations: adjusted EBITDA turned positive at 2.70 million US dollars, while the contracted backlog reached about 1.10 billion US dollars as of March 31, 2026, with approximately 60%–65% guided to convert to revenue in 2026. Within the quarter, fixed‑price contracts generated 162.09 million US dollars, supported by reimbursable expenses of 19.30 million, grants of 3.10 million, and time‑and‑materials work of 2.24 million, against a backdrop of total revenue growth of 198.65% year over year.Current Quarter Outlook
Main business execution and revenue conversion
Management’s delivery cadence and revenue recognition from existing awards form the crux of this quarter’s narrative. With an estimated 216.33 million US dollars of revenue in the current quarter, the market is looking for continued conversion of milestone-based deliverables from the sizable contracted book that expanded earlier this year. The company has emphasized that 60%–65% of its 1.10 billion US dollars backlog (as of March 31, 2026) is expected to convert into 2026 revenue, and this quarter is a key checkpoint on that trajectory. Investors will parse whether the revenue phasing remains on track with program schedules and whether any scope or timing changes emerge that could shift recognition into later periods.Gross margin is a flashpoint given the mix between fixed‑price and cost‑reimbursable work. Last quarter’s 16.12% gross margin reflected early-phase scale-up and the cost profile of mission work executed across programs. This quarter’s margin outcome will swing on two levers: milestone timing relative to higher‑margin deliverables and the proportion of reimbursable engineering services that typically carry lower absolute margin but steadier cash conversion. In parallel, the EBIT outlook at -15.08 million US dollars, alongside a forecast EPS of -0.10, suggests continuing investment to integrate recent acquisitions and build delivery capacity; however, scale benefits from revenue growth could narrow operating losses sequentially if overhead absorption improves.
Cash discipline and working capital are also under the microscope. Last quarter’s operations demonstrated significant throughput, and adjusted EBITDA briefly turned positive, but the company’s working capital needs can swell during mission integration and hardware procurement windows. The cadence of customer advances and milestone billings—particularly on larger awards—can offset these demands; clarity on billing schedules and collections will shape expectations for operating cash flow in the second half of the year. Any reiteration or refinement of full‑year revenue guidance in the range of 900.00 million–1.00 billion US dollars, together with the path to sustained positive EBITDA, would likely define investor reaction to the print.
Fixed‑price missions as the growth engine
Fixed‑price contracts remain the largest contributor and the most visible growth engine, evidenced by 162.09 million US dollars of revenue last quarter. This segment’s near-term momentum is tied to program milestones that can produce step‑function revenue recognition as deliverables are accepted. The addition of new awards, including a contract valued at up to 148.30 million US dollars, strengthens the forward pipeline and underpins the current quarter’s revenue forecast. The performance incentive structure embedded in certain awards creates upside optionality tied to qualification achievements, though the timing of recognition may skew toward later quarters depending on when acceptance criteria are met.The underlying economics of fixed‑price work hinge on execution fidelity—staying within budgeted materials, integration, and testing costs to protect gross margins. Management’s ability to manage supplier lead times, coordinate system tests, and execute flight‑critical milestones without rework is key to margin stability. This quarter’s disclosure on cost performance—especially whether identified cost‑savings or integration synergies are tracking to plan—will inform the sustainability of margin recovery from last quarter’s 16.12%. Additionally, as volume rises, the benefit of overhead absorption could widen the spread between revenue growth and operating cost growth, improving EBIT from the -39.20 million US dollars posted last quarter toward the current forecast of -15.08 million US dollars.
Beyond milestone deliveries, the pipeline is broadening with civil, national security, and commercial demand contributing to mix stability. Last quarter, management highlighted that the revenue base included meaningful contributions across these customer categories, which can diversify timing risk and smooth the delivery curve. The company’s opportunity set for incremental awards—paired with acceptance of completed milestones—could inform whether revenue continues to outpace cost growth over the next several quarters, a necessary condition for sustained EBITDA and EPS improvement.
What will move the stock this quarter
Two sets of variables are likely to drive share‑price reactions around the release: the earnings math and the funding/contracting narrative. On earnings, the headline metrics the market is primed for are revenue of 216.33 million US dollars (up 224.78% year over year), EPS of -0.10 (with a year‑over‑year forecast growth ratio of -8202.56% due to a very small base period denominator), and the degree of improvement in operating losses from last quarter’s -39.20 million US dollars of EBIT to the current forecast of -15.08 million US dollars. Any outperformance on gross margin or a better‑than‑expected EPS loss—especially if accompanied by solid operating cash flow—would likely be received favorably.On the funding and program side, investors will watch progress on recent and pending transactions. The integration of recently acquired assets is aimed at deepening engineering and production capacity; management commentary on synergy realization and cost baselines will be closely read. The market has also tracked an at‑the‑market or shelf capacity for potential equity issuance of up to 500.00 million US dollars; clarity on whether, and under what conditions, the company intends to draw on that authorization matters to equity holders’ dilution math and to the balance sheet’s flexibility for program execution. Conversely, incremental awards—such as the previously announced contract valued at up to 148.30 million US dollars—help reinforce the revenue runway and can mitigate concerns about external financing if milestone payments scale with delivery.
A third driver is guidance. The company previously raised its full‑year 2026 revenue outlook to 900.00 million–1.00 billion US dollars while targeting positive adjusted EBITDA for the year. On August 13, 2026, investors will look for confirmation that second‑half deliveries and qualification activities remain aligned with that range, and whether the conversion rate from the 1.10 billion US dollars backlog remains intact. Precision around second‑half milestone timing, any major customer‑driven schedule shifts, and the updated margin framework can collectively reset the market’s base case beyond Q2, which would be a material catalyst for the shares.
Analyst Opinions
Bullish opinions constitute the clear majority among named sell‑side voices observed year‑to‑date, with notable firms reiterating positive ratings and raising targets as execution scaled. B. Riley maintained a Buy rating and increased its price target to 40.00 US dollars, citing accelerating contract conversion, expanding revenue visibility, and a pathway toward sustained positive adjusted EBITDA as the company integrates recent acquisitions. Craig‑Hallum’s Jeff Van Rhee also reaffirmed a Buy rating with a 42.00 US dollars target, emphasizing the impact of newly awarded contracts—such as the up‑to‑148.30 million US dollars award—and the potential for milestone acceptance to drive revenue recognition at a pace that outstrips fixed overhead growth.The bullish cohort places particular weight on three factors this quarter. First, the steep year‑over‑year revenue trajectory—current quarter estimate up 224.78%—is viewed as validation that contract wins are translating into deliverables, not just headline backlog. Analysts argue that the fixed‑price mission base, which generated 162.09 million US dollars last quarter, remains the fulcrum for upside surprises when acceptance events cluster. Second, margin progression is expected to benefit from scale and from the shift toward deliverables that carry better unit economics as programs mature, even as reimbursable engineering work provides a steady baseline of activity. The bullish case envisions gross margin gradually improving from last quarter’s 16.12% as larger milestones are completed, with operating losses narrowing from -39.20 million US dollars of EBIT toward the current -15.08 million US dollars estimate.
Third, the funding and contracting equation is seen as manageable in light of recent awards and the company’s ability to access capital when needed. While investors remain attentive to the possibility of equity issuance from a 500.00 million US dollars authorization, bullish analysts contend that strong contract momentum and milestone cash receipts can bridge working capital needs through the second half, reducing the near‑term necessity to issue shares at depressed prices. They also highlight that incremental awards—like the up‑to‑148.30 million US dollars contract—provide not only revenue but also potential performance incentives that, upon achieving qualification, could augment cash inflows and earnings power in later periods.
Within this framing, the majority view expects the August 13, 2026 Pre‑Mkt release to underscore continued revenue scaling, improved operating leverage, and reaffirmed full‑year revenue and EBITDA trajectories. The critical datapoints these analysts want to see include: confirmation of backlog conversion pacing consistent with 60%–65% for 2026, a gross margin print that demonstrates stability or improvement from 16.12% despite mix variability, and commentary that delineates the timeline for key milestone acceptances in the second half. Should these elements align with the current quarter’s 216.33 million US dollars revenue estimate and the company reiterate its 900.00 million–1.00 billion US dollars full‑year target, the bullish case anticipates that the shares could begin to discount 2027 earnings power tied to the expanding contract base and maturing program economics.
Market behavior around the name in recent months also supports the bullish stance. The shares have been sensitive to sector‑wide swings, yet positive flows followed high‑profile contract announcements and incremental institutional interest, signaling that investors are responding to execution markers rather than headlines alone. Against that backdrop, the majority of analysts reviewing the quarter frame the risk/reward as hinging on delivery cadence, not demand, and expect the print to provide additional evidence that the company’s operating model can translate contracted backlog into recognized revenue with improving margin characteristics. In sum, the prevailing institutional view is bullish, anchored in tangible contract conversion, a widening revenue base, and a credible road map toward positive adjusted EBITDA, even as the company continues to invest for scale.
Comments